Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Kimberly Clark Corp — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Kimberly Clark Corp trades at $100.4 (market cap $33.06B). The key difference: Kimberly Clark Corp is far larger — about 4.7× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Kimberly Clark Corp pays a 5.15% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Kimberly Clark Corp for 94 Days on average.
| IONS | KMB | |
|---|---|---|
Market Cap | $7.10B | $33.06B |
Volume | 2,027,457 | 6,233,100 |
Sector | Health | Consumer Staples |
52-Week High | $86.50 | $121.44 |
52-Week Low | $42.38 | $93.05 |
Typical Hold Time | 0 Days | 94 Days |
Enterprise Value | $6.66B | $38.62B |
Dividend Yield | — | 5.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kimberly-Clark (KMB) trades at $98.29, down 0.49% on the day, showing bearish technical momentum with the stock near key support levels. The company maintains solid profitability with 11.79% net margins and has beaten earnings estimates in 2 of the last 3 quarters. Recent executive transitions and the pending Kenvue acquisition create both opportunities and uncertainties for the consumer staples giant.
KMB offers a compelling 5.2% dividend yield with 54 consecutive years of increases, though cash flow sustainability remains a concern. Analyst consensus targets $117.25 (19% upside) but the stock faces headwinds from integration risks and competitive pressures in the personal care market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
